Sec. 2. Continuing support for research on endemic fungal diseases

645 words·~3 min read·/bill/116/s/1567/is/section-2

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The Public Health Service Act is amended by inserting after section 320A of such Act ( 42 U.S.C. 247d–8 ) the following new section: The Secretary shall continue to conduct or support epidemiological, basic, translational, and clinical research related to endemic fungal diseases, including coccidioidomycosis (commonly known as and referred to in this section as Valley Fever ). The Secretary shall ensure that each triennial report under section 403 includes information on actions undertaken by the National Institutes of Health to carry out subsection

(a)with respect to endemic fungal diseases, including Valley Fever. The Secretary shall establish a working group, to be known as the Endemic Fungal Disease Working Group (referred to in this section as the Working Group ), comprised of representatives of appropriate Federal agencies and other non-Federal entities— to provide expertise and to review all efforts within the Department of Health and Human Services related to endemic fungal disease; to help ensure interagency coordination and minimize overlap with respect to such disease; and to examine research priorities with respect to such disease. The Working Group shall— not later than 2 years after the date of enactment of the FORWARD Act of 2019 , develop or update a summary of— ongoing endemic fungal disease research, including research related to causes, prevention, treatment, surveillance, diagnosis, diagnostics, duration of illness, and intervention for individuals with an endemic fungal disease; advances made pursuant to such research; Federal activities related to endemic fungal disease, including— epidemiological activities related to endemic fungal disease; and basic, clinical, and translational endemic fungal disease research related to the pathogenesis, prevention, diagnosis, and treatment of endemic fungal disease; gaps in endemic fungal disease research described in clause (iii)(II); the Working Group’s meetings required under paragraph (4); and the comments received by the Working Group; make recommendations to the Secretary regarding any appropriate changes or improvements to such activities and research; and solicit input from States, localities, and nongovernmental entities, including organizations representing patients, health care providers, researchers, and industry regarding scientific advances, research questions, and surveillance activities. The members of the Working Group shall represent a diversity of scientific disciplines and views and shall be composed of the following members: Seven Federal members, consisting of one or more representatives of each of the following: The Office of the Assistant Secretary for Health. The Food and Drug Administration. The Centers for Disease Control and Prevention. The National Institutes of Health. Such other agencies and offices of the Department of Health and Human Services as the Secretary determines appropriate. Seven non-Federal public members, consisting of representatives of the following categories: Physicians and other medical providers with experience in diagnosing and treating endemic fungal disease. Scientists or researchers with expertise. Patients and their family members. Nonprofit organizations that advocate for patients with respect to endemic fungal disease. Other individuals whose expertise is determined by the Secretary to be beneficial to the functioning of the Working Group. The Working Group shall meet annually. Not later than 2 years after the date of enactment of the FORWARD Act of 2019 , and every 2 years thereafter until termination of the Working Group pursuant to paragraph (7), the Working Group shall— submit a report on its activities under paragraph (2)(A) and any recommendations under paragraph (2)(B) to the Secretary, the Committee on Energy and Commerce of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions of the Senate; and make such report publicly available on the internet website of the Department of Health and Human Services. The Working Group shall be treated as an advisory committee subject to the Federal Advisory Committee Act (5 U.S.C. App.). The Working Group under this section shall terminate 5 years after the date of enactment of the FORWARD Act of 2019 . In this section, the term endemic fungal disease means blastomycosis, coccidioidomycosis, histoplasmosis, and sparotrichosis. .

Connections1 off-index

1 reference not yet in our index

42 USC 247d–8

Citation graph

cites case law

Sec. 2

Continuing support for research on endemic fungal diseases

Cite42 USC 247d–8

Cites 1Cited by 0 across 0 sources